CN Patent

CN110624274B — 分离介质及其制备方法和应用

Assigned to Suzhou saifen Technology Co.,Ltd. · Expires 2021-04-13 · 5y expired

What this patent protects

本发明涉及一种分离介质及其制备方法和应用。该分离介质具有如式I所示结构：其中，SP为介质，R为间隔臂，rProtein A‑cys为重组蛋白A。本发明提供的新的分离介质，其动态结合载量达到50mg/mL，分离效率高、分离效果好、成本低，适合工业化大规模分离纯化抗体及Fc融合蛋白。

USPTO Abstract

本发明涉及一种分离介质及其制备方法和应用。该分离介质具有如式I所示结构：其中，SP为介质，R为间隔臂，rProtein A‑cys为重组蛋白A。本发明提供的新的分离介质，其动态结合载量达到50mg/mL，分离效率高、分离效果好、成本低，适合工业化大规模分离纯化抗体及Fc融合蛋白。

Drugs covered by this patent

Patent Metadata

Patent number: CN110624274B
Jurisdiction: CN
Classification: —
Expires: 2021-04-13
Drug substance claim: No
Drug product claim: No
Assignee: Suzhou saifen Technology Co.,Ltd.
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.